SAN FRANCISCO - Bruker Corporation (NASDAQ:BRKR) has acquired AST Revolution, LLC, a developer of rapid antimicrobial susceptibility testing solutions, according to a press release statement from ...

It flipped to a GAAP net loss in its third quarter, although on a non-GAAP basis it was in the black. It beat on both the top and bottom lines. Bruker, which specializes in the supply of medical ...

(1) We define the term acquisitions revenue as GAAP revenue from M&A activities excluding the effect of changes in foreign currency translation rates. (2) We define the term organic revenue as GAAP ...

The company is tapping the market for at least $600 million in fresh capital. It will use the funds chiefly to retire debt. Just after market close on Tuesday, Bruker announced that it was floating a ...

Shares of Bruker slipped after the maker of scientific products started a public offering of $600 million of Series A mandatory convertible preferred stock. The stock was 13% lower, at $28.86, midday ...

Bruker Corporation (NASDAQ:BRKR) reported worse-than-expected second-quarter financial results and cut its FY25 guidance on Monday. Bruker reported quarterly earnings of 32 cents per share which ...

Shares of Bruker fell after the company reported preliminary second-quarter results that missed Wall Street's expectations, hurt by what it called weak academic demand and a soft biopharma market in ...

Bruker Corporation today announced the launch of the MOVE-T, a state-of-the-art liquid dairy analyzer designed to elevate quality control standards in the dairy industry. Utilizing advanced Fourier ...

Bruker Corporation today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving ...

Bruker Corporation's stock has dropped approximately 60% in the past year, despite beating Q4 earnings expectations and some recent insider purchases. The company, a leader in scientific instruments ...

Bruker Corporation announced the launch of the LUMOS™ II ILIM , a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma ...